
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Lifordi is among the first companies to leverage the success of antibody-drug conjugates (ADC) in oncology to develop treatments for autoimmune and inflammatory disorders. We have demonstrated superior efficacy in multiple preclinical diseases models by targeting myeloid and lymphoid cells using a highly internalized cell surface membrane protein. As experienced drug developers with expertise in immunology and inflammatory diseases, a strong partnering track record, and funding from ARCH Venture Partners, 5AM Ventures, and Atlas Venture to support initial clinical data, we can change how immune and inflammatory diseases are treated
Lifordi immunotherapeutics, inc operates in the Biotechnology research industry.
Lifordi immunotherapeutics, inc's revenue is 11m - 100m
Lifordi immunotherapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.